EUVIMEDEUVIMED entdecken
Crossref

Genetic determinants of chylomicronemia in Taiwan: Predominance of LPL rare variants and APOA5 p.G185C

Eric Bo-Ru Chao, Siao-Jyuan Jhan, Po-Chih Lin, Yuh-Tsyr Chou, Wen-Chi Chang, Allen Chilun Luo, Mao-Jan Lin, Ching-Hua Kuo, Yu-An Chen, Pei-Lung Chen, Ta-Chen Su

Journal of Clinical Lipidology · 2026-09 · 20 (9) · 1850-1862

DOI: 10.1016/j.jacl.2026.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2026-09. Verfasst von Eric Bo-Ru Chao und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, National Taiwan University, Taipei 10617, Taiwan (Chao and Su). Hauptthemen laut MEDLINE: Apolipoprotein A-V, Lipoprotein Lipase, Hyperlipoproteinemia Type I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Taiwan Ministry of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chylomicronemia is a genetically heterogeneous condition with both genetic and environmental determinants. Genetic studies have largely focused on European populations, with limited data from East Asians, particularly Han Chinese. We characterized the genetic profiles of chylomicronemia patients of mainly Han Chinese ancestry in Taiwan. OBJECTIVE: To identify and classify disease-causing variants in chylomicronemia patients. METHODS: Capture-based targeted next-generation sequencing was performed for 108 chylomicronemia patients to assess hypertriglyceridemia-related genes, including those harboring large- and moderate-effect rare variants, and small-effect single-nucleotide variants. RESULTS: Twenty-seven patients (25%) carried large-effect, disease-causing rare variants, the majority in LPL (86%), with additional variants identified in APOA5, LMF1, and APOA1. The most prevalent variant, NM_000237.3(LPL):c.835C>G(p.L279V), was detected in all homozygous and compound heterozygous cases. Comparison with the Taiwan Biobank revealed significant differences in APOE allele and genotype distributions (P = 0.003492 and P = 0.009, respectively). Additionally, NM_001371904.1(APOA5): c.553G>T(p.G185C) was identified in 43.5% of patients, showing a high prevalence despite not being classified as a large-effect variant, and frequently found without additional large-effect rare variants. CONCLUSION: As one of the most comprehensive characterizations to date of chylomicronemia in an East Asian cohort, the predominance of large-effect LPL rare variants, together with the high prevalence of the APOA5 p.G185C variant and distinct APOE allele distributions, highlights population-specific genetic architecture.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein A-VLipoprotein LipaseHyperlipoproteinemia Type IHumansTaiwanFemaleMalePolymorphism, Single NucleotideMiddle AgedAdult

Stichwörter der Autor:innen

ACMG variant classificationAPOA5 p.G185CAPOEChylomicronemiaHan Chinese populationHypertriglyceridemia (HTG)Lipoprotein lipase (LPL)Next‑generation sequencing (NGS)Taiwan Biobank (TWB)Targeted sequencing

Substanzen

Apolipoprotein A-VLipoprotein LipaseAPOA5 protein, humanLPL protein, human

Autor:innen und Institutionen

  • School of Medicine, College of Medicine, National Taiwan University, Taipei 10617, Taiwan (Chao and Su).
  • Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei 10617, Taiwan (Jhan and Pei-Lung Chen).
  • Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan (Lin and Su).
  • Graduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei 10617, Taiwan (Chou, Luo, Yu-An Chen, and Pei-Lung Chen).
  • Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan (Chang).
  • Department of Medical Genetics, National Taiwan University Hospital, Taipei 10002, Taiwan (Lin and Pei-Lung Chen).

Förderung

  • Taiwan Ministry of Science and Technology

Zitieren

APA

Chao, E. B., Jhan, S. J., Lin, P. C., Chou, Y. T., Chang, W. C., Luo, A. C., Lin, M. J., Kuo, C. H., Chen, Y. A., Chen, P. L., & Su, T. C. (2026). Genetic determinants of chylomicronemia in Taiwan: Predominance of LPL rare variants and APOA5 p.G185C. Journal of Clinical Lipidology, 20(9), 1850-1862. https://doi.org/10.1016/j.jacl.2026.07.005

Vancouver

Chao EB, Jhan SJ, Lin PC, Chou YT, Chang WC, Luo AC, et al. Genetic determinants of chylomicronemia in Taiwan: Predominance of LPL rare variants and APOA5 p.G185C. Journal of Clinical Lipidology. 2026;20(9):1850-1862. doi:10.1016/j.jacl.2026.07.005

BibTeX
@article{Chao2026,
  author = {Chao, Eric Bo-Ru and Jhan, Siao-Jyuan and Lin, Po-Chih and Chou, Yuh-Tsyr and Chang, Wen-Chi and Luo, Allen Chilun and Lin, Mao-Jan and Kuo, Ching-Hua and Chen, Yu-An and Chen, Pei-Lung and Su, Ta-Chen},
  title = {Genetic determinants of chylomicronemia in Taiwan: Predominance of LPL rare variants and APOA5 p.G185C},
  journal = {Journal of Clinical Lipidology},
  year = {2026},
  volume = {20},
  number = {9},
  pages = {1850--1862},
  doi = {10.1016/j.jacl.2026.07.005}
}
Kostenlos starten →